Mireille
Mireille Ainciburu, Sussargues FR
Patent application number | Description | Published |
---|---|---|
20100255466 | Method for the in vitro diagnosis of bronchopulmonary carcinoma by detection of major alternative transcripts of the klk8 gene encoding kallicrein 8 and use thereof for prognosticating survival - The present invention relates to a method for the in vitro diagnosis of bronchopulmonary carcinoma, in particular of non-small cell bronchial carcinoma, characterized in that it comprises the stage of detecting, in a biological sample derived from a patient suspected to be suffering from said bronchopulmonary carcinoma, at least one of the major alternative transcripts of the KLK8 gene encoding kallikrein 8. This method is particularly useful for the survival prognostication of patients suffering from bronchopulmonary carcinoma. | 10-07-2010 |
20120295261 | METHOD FOR THE IN VITRO DIAGNOSIS OF BRONCHOPULMONARY CARCINOMA BY DETECTION OF MAJOR ALTERNATIVE TRANSCRIPTS OF THE KLK8 GENE ENCODING KALLICREIN 8 AND USE THEREOF FOR PROGNOSTICATING SURVIVAL - A method for the in vitro diagnosis of bronchopulmonary carcinoma, in particular of non-small cell bronchial carcinoma, that includes a stage of detecting, in a biological sample derived from a patient suspected to be suffering from bronchopulmonary carcinoma, at least one of the major alternative transcripts of the KLK8 gene encoding kallikrein 8. This method is particularly useful for the survival prognostication of patients suffering from bronchopulmonary carcinoma. | 11-22-2012 |
20130289260 | NT5 AND NT6 ALTERNATIVE TRANSCRIPTS OF THE KLK8 GENE ENCODING KALLIKREIN 8 - Newly discovered alternative transcripts of the KLK8 gene encoding kallikrein 8, NT5 and NT6. The sequence of NT5 is set forth in SEQ ID NO:7, and the sequence of NT6 is set forth in SEQ ID NO:8. | 10-31-2013 |
Mireille Blanchard-Desce, Rennes FR
Patent application number | Description | Published |
---|---|---|
20090221819 | FLUORESCENT COMPOUNDS AND USE OF SAID COMPOUNDS IN MULTIPHOTON METHODS OR DEVICES - The invention relates to a chemical compound with an effective double photon absorbance section of greater than 50 GM, preferably greater than 100 GM, for at least one wavelength in the range 700-1200 nm, characterised in being made up of a core with double photon absorption properties connected by separate covalent bonds to at least two boron dipyrromethene type emitters of formula (—BDP) (I): where one of R | 09-03-2009 |
20100105144 | ONIUM SALTS AND USE THEREOF FOR DETECTING AND ASSAYING METALS - Task-specific onium salts, process for preparing them and use thereof for detecting and assaying metals, in particular heavy metals, in an aqueous medium. | 04-29-2010 |
20100266506 | Flourescent Dendrimer Compounds and Use of Such Compounds in Multi-Photon Devices or Processes - Fluorescent chemical compound composed of an n-generation dendrimer, n being a non-zero integer, exhibiting: -at least one central nucleus (N) with a valency of m, selected from the group consisting of -at least one first, non-chromophoric unit (X) with a valency of m′, and -at least one second unit (Y) which exhibits two-photon absorption properties, with a valency of m″. | 10-21-2010 |
20130065849 | BIPHOTONIC PHOTOSENSITIZERS, NANOPARTICLES CONTAINING THE SAME AND THEIR USE AS DRUGS - The invention relates to compounds of formula (I) | 03-14-2013 |
Mireille Cavaleyra, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20140193452 | NOVEL AGENTS FOR THE PREVENTION OF LEISHMANIASIS - The invention relates to nucleic acid constructions, characterized in that they comprise nucleic acids which are isolated in the sense position and which are capable of coding for an immunogenic protein of promastigotes or amastigotes of | 07-10-2014 |
Mireille Cheinet, Saint Egreve FR
Patent application number | Description | Published |
---|---|---|
20150082141 | DOCUMENTATION DATA FILE WITH DETAIL LEVELS - A method and device is described for saving a documentation data file intended for being displayed on a screen. The method includes subdividing the documentation data into data blocks; associating a detail level with at least one data block; and saving the data block with a level marker relating to the associated detail level, the marker intended to be compared with a desired detail level in order to display the data on the screen. | 03-19-2015 |
Mireille Chinain, Pirae FR
Patent application number | Description | Published |
---|---|---|
20120196929 | Use of Rosmarinic Acid and the Derivaties Thereof to Treat Ciguatera - The present invention relates to rosmarinic acid and to the derivatives thereof, expressed by the compounds of general formula (I), for the use thereof to prevent and/or treat disorders caused by ciguatoxin poisoning and for preparing a pharmaceutical composition for preventing and/or treating disorders caused by ciguatoxin poisoning. | 08-02-2012 |
Mireille Cossee, Montpellier FR
Patent application number | Description | Published |
---|---|---|
20150247196 | IN VITRO GENETIC DIAGNOSTIC OF INHERITED NEUROMUSCULAR DISORDERS - The present invention provides a method for determining all the molecular causes of Inherited Neuromuscular Disorders comprising determining a number of copy number variation(s), and/or determining a number of point mutation(s) on a physiological sample comprising a genome of a subject. | 09-03-2015 |
Mireille Henry-Mary, Greasque FR
Patent application number | Description | Published |
---|---|---|
20100075306 | METHOD FOR DIAGNOSIS OF AND FOLLOWING A BACTERIAL VAGINOSIS BY MOLECULAR QUANTIFICATION - The present invention relates to a method for in vitro diagnosis and follow-up of vaginal bacterial flora status in relation to the presence of bacterial vaginosis, and for monitoring its treatment where applicable, wherein the presence of bacterial vaginosis or failure of on-going treatment is determined if the concentrations of specific sequences present in a single copy in the DNA of the bacteria | 03-25-2010 |
20120252012 | METHOD FOR DETECTING PROKARYOTIC DNA FROM A FECES SAMPLE - The present invention concerns a method of detection and preferably of quantification of DNA, preferably comprising prokaryotic DNA, extracted from a stool sample of an individual, especially for the molecular determination of the composition of the intestinal flora in the stool. According to the invention, one controls the quality of the DNA extraction by verifying whether one detects a specific DNA of | 10-04-2012 |
Mireille Jacomino, Echirolles FR
Patent application number | Description | Published |
---|---|---|
20130041478 | SYSTEM AND METHOD FOR MANAGING SERVICES IN A LIVING PLACE - A system is provided for managing services in a living place, including: | 02-14-2013 |
20150236531 | RECHARGING OF A POOL OF BATTERIES - The method for managing the charging of a pool of batteries on the basis of a charging system ( | 08-20-2015 |
Mireille Pauliac, Aubagne FR
Patent application number | Description | Published |
---|---|---|
20080293377 | Reuse of Identity Data from a User Equipment Identity Module by a Peripheral Device - The invention relates to the reuse of identity data from an identity module in a user equipment by a peripheral device. In order to enable the reuse of identity data from an identity module, such as a SIM or UICC card, in a user equipment by a peripheral device, the identifier of the peripheral device is transmitted to the module upon establishment of communication and authentication between the module and the peripheral device. Subsequently, identity data are transmitted, preferably selectively, by the identity module to the peripheral device when the transmitted identifier is recognized as one of the identifiers of the peripheral devices that were previously stored in the identity module. The identity data are reused by the peripheral device in order to establish a communication with the home network of the user equipment or with a local wireless network. | 11-27-2008 |
20120164981 | METHOD FOR COMMUNICATING DATA BETWEEN A SECURE ELEMENT AND A NETWORK ACCESS POINT AND A CORRESPONDING SECURE ELEMENT - The invention relates to a method for communicating data between a first secure element and a network access point. The first secure element is coupled with a network access point. The network access point is comprised within a communication network. According to the invention, at least one of the first secure element and the network access point sends, to the other of the network access point and the first secure element respectively, data relating to an identity of a communication link, as logical link, between the first secure element and the network access point. The invention also relates to a corresponding secure element. | 06-28-2012 |
20160044505 | METHOD TO ESTABLISH A SECURE VOICE COMMUNICATION USING GENERIC BOOTSTRAPPING ARCHITECTURE - The present invention relates to a method to establish a secure voice communication session between two user equipments with the help of a dedicated Network Application Function (NAF) and at least one Bootstrapping Server Function. A session key is calculated from bootstrapping service derived external or internal NAF keys of the first and the second user equipments. A secured voice communication is established using the calculated session key. | 02-11-2016 |
Mireille Pauliac, Meudon FR
Patent application number | Description | Published |
---|---|---|
20150149765 | METHOD OF ANONYMIZATION - This invention is aimed at a method for the anonymisation of data that could help identify the user while a profile of said user is collected by a targeting data collection server. To implement such anonymisation, an anonymisation server is placed between a user terminal and the collections server. The profile data collected are encrypted by the terminal using a secret key shared with the data collection server. Those profile data supplemented with data that could help identify the user are then sent to the anonymisation server. The anonymisation server encrypts the data that could help identify the user with an anonymisation key of said anonymisation server before sending on the encrypted collected data and the anonymised identification data to said collection server. | 05-28-2015 |
Mireille Prince-David, Lomé TG
Patent application number | Description | Published |
---|---|---|
20160095879 | COMPOSITION FOR ENHANCING IMMUNITY - The invention relates to preparations for dietary, food supplement or medical purposes and more specifically to a safe and natural preparation or a composition useful in immunity regulation and/or stimulation and in particular in the building, reinforcement, efficiency, maintenance and regeneration of natural immune defences in a subject. The preparations comprise magnesium, zinc and/or iron, blackcurrent seed oil and/or palm oil, two plant extracts selected from thyme, chickpea and lentil, as well as algae (fucus, wakame, nori), mushroom (shiitake, maitake) and at least one hydrosoluble vitamin and/or vitamin E. | 04-07-2016 |
Mireille Richard-Plouet, Suce Sur Erdre FR
Patent application number | Description | Published |
---|---|---|
20150024539 | FORMULATION OF COLLOIDAL TITANIUM-OXIDE SOLUTIONS COMPOSITION FOR COATING AND PRINTING METHODS, AND IMPROVEMENT OF THE OUTPUT AND LIFESPAN OF ORGANIC P-I-N/N-I-P PHOTOVOLTAIC CELLS - The invention relates to a method for preparing a colloidal nanoparticle solution, including: (a) dissolving a titanium-oxide precursor, referred to as a precursor, in one or more solvents, referred to as precursor solvents; and (b) chemically converting, preferably by means of hydrolysis, said titanium-oxide precursor and said precursor solvent into a colloidal-solution solvent so as to form titanium-oxide nanoparticles that are dispersed in the colloidal-solution solvent, said colloidal solution having a dynamic viscosity of between 4 and 54 cP at 20° C. and 101,325 Pa. | 01-22-2015 |
Mireille Sauvage-Vita, Gif Sur Yvette FR
Patent application number | Description | Published |
---|---|---|
20090285798 | CD4 MIMIC PEPTIDES AND THEIR USES - An isolated peptide comprising the sequence (I): TPA-Asn-Leu-His-Phe-Cys-Gln-Leu-Xaa | 11-19-2009 |
20100015056 | Uranium-chelating peptides and uses thereof - The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence. | 01-21-2010 |
20110093964 | URANIUM-CHELATING PEPTIDES AND USES THEREOF - The invention concerns uranium-chelating peptides as well as their uses for decontaminating soils and water, and for detecting and treating people contaminated by uranium. Said peptides have a helix-loop-helix type structure comprising the sequence of a calmodulin loop including at least one mutation of neutral residues selected from the group consisting of S, T, C, H, Y, N and Q, of one, two or three residues of at least one of the four calmodulin calcium binding sites: site I: residues selected among D20, D22 and D24 residues; site II: residues selected among D56, D58 and N60 residues; site III: residues selected among D93, D95 and N97 residues; site IV: residues selected among D129, D131 and D133 residues; said positions being indicated with reference to the human calmodulin sequence. | 04-21-2011 |
Mireille Sebbag, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20090028885 | CITRULLINE PEPTIDES DERIVED FROM FIBRIN AND RECOGNIZED BY RHEUMATOID ARTHRITIS SPECIFIC AUTOANTIBODIES, AND THE USE THEREOF - The invention relates to novel citrulline peptides derived from fibrin α and β chains which are recognisable by specific citrulline antiprotein autoantibodies (AAPC) of a rheumatoid arthritis (PR) and to the use thereof for detecting the presence of said specific PR AAPC in a biological sample. | 01-29-2009 |
20090298778 | Peptides Modulating the Activity of Macrophages, Useable for the Treatment of Rheumatoid Arthritis - The invention relates to citrulline peptides with anti-inflammatory properties. The invention also relates to an in vitro model for activation of macrophages, induced by immune complexes between specified IgG of rheumatoid arthritis and their citrulline targets. | 12-03-2009 |
20130028922 | CITRULLINE PEPTIDES DERIVED FROM FIBRIN AND RECOGNIZED BY RHEUMATOID ARTHRITIS SPECIFIC AUTOANTIBODIES, AND THE USE THEREOF - The invention relates to novel citrulline peptides derived from fibrin α and β chains which are recognizable by specific citrulline antiprotein autoantibodies (AAPC) of a rheumatoid arthritis (PR) and to the use thereof for detecting the presence of said specific PR AAPC in a biological sample. | 01-31-2013 |
Mireille Sevrin, Paris FR
Patent application number | Description | Published |
---|---|---|
20090143380 | 2H- OR 3H-BENZO[E]INDAZOL-1-YL CARBAMATE DERIVATIVES, THE PREPARATION AND THERAPEUTIC USE THEREOF - Compounds corresponding to the formula (I) | 06-04-2009 |
20120108584 | 2H OR 3H-BENZO[E]INDAZOL-1-YL CARBAMATE DERIVATIVES, THE PREPARATION AND THERAPEUTIC USE THEREOF - Compounds corresponding to the formula (I) | 05-03-2012 |
20130190314 | DERIVATIVES OF 6-CYCLOAMINO-2-THIENYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND 6-CYCLOAMINO-2-FURANYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE, PREPARATION AND THERAPEUTIC USE THEREOF - The invention relates to derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine with general formula (I). The invention also relates to a method for the preparation and therapeutic application thereof, in the treatment or prevention of illnesses involving casein kinase 1 epsilon and/or casein kinase 1 delta. | 07-25-2013 |
Mireille Sodoyer, Sainte Foy Les Lyon FR
Patent application number | Description | Published |
---|---|---|
20100285448 | RETROVIRAL NUCLEIC MATERIAL AND NUCLEOTIDE FRAGMENTS, IN PARTICULAR ASSOCIATED WITH MULTIPLE SCLEROSIS AND/OR RHEUMATOID ARTHRITIS, FOR DIAGNOSTIC, PROPHYLACTIC AND THERAPEUTIC USES - An isolated polynucleotide having a nucleotide sequence selected from the group consisting of (a) SEQ ID NO: 21, (b) the full-length sequences encoding a polypeptide having a peptide sequence selected from the group consisting of SEQ ID NOs: 25 and 26, and (c) the full-length complementary sequences to the sequences set forth in (a) or (b). | 11-11-2010 |
Mireille Tallander, Bretigny FR
Patent application number | Description | Published |
---|---|---|
20110178150 | Use of Indole Derivatives as NURR-1 Activators for Treating Parkinson's Disease - The present invention relates to a compound derived from indole, especially a therapeutically useful compound, characterized in that it is selected from compounds of formula (I) | 07-21-2011 |
Mireille Van Gele, Adegem (maldegem) BE
Patent application number | Description | Published |
---|---|---|
20090239934 | Anti-Myosin Va siRNA and Skin Depigmentation - The present invention relates to novel isolated siRNAs comprising a sense RNA strand and a complementary antisense RNA strand which together form an RNA duplex, characterized in that the sense RNA strand comprises a sequence which has at most one nucleotide that is distinct in relation to a fragment of 14 to 30 contiguous nucleotides of the nucleotide sequence of exon F of the gene encoding the myosin Va protein, and also to compositions comprising at least one such siRNA, and to the use of at least one such siRNA as a cosmetic or therapeutic agent for skin depigmentation. | 09-24-2009 |